BAFF/APRIL system is functional in B-cell acute lymphoblastic leukemia in a disease subtype manner

Autor: Sevdali, E. Katsantoni, E. Smulski, C.R. Moschovi, M. Palassopoulou, M. Kolokotsa, E.N. Argentou, N. Giannakoulas, N. Adamaki, M. Vassilopoulos, G. Polychronopoulou, S. Germenis, A.E. Eibel, H. Speletas, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::47b85d0a2911f7cdddd27a682a1a092a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078899

BAFF/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner.

Autor: Sevdali E; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Katsantoni E; Basic Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Smulski CR; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg im Breisgau, Germany., Moschovi M; Hematology/Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Medical School, 'Aghia Sophia' Children's Hospital, Athens, Greece., Palassopoulou M; Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Kolokotsa EN; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Argentou N; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Giannakoulas N; Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Adamaki M; Hematology/Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Medical School, 'Aghia Sophia' Children's Hospital, Athens, Greece., Vassilopoulos G; Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Polychronopoulou S; Department of Pediatric Hematology/Oncology, 'Aghia Sophia' Children's Hospital, Athens, Greece., Germenis AE; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Eibel H; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg im Breisgau, Germany., Speletas M; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Publikováno v: Frontiers in oncology [Front Oncol] 2019 Jul 18; Vol. 9, pp. 594. Date of Electronic Publication: 2019 Jul 18 (Print Publication: 2019).

TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.

Autor: Argentou N; Department of Immunology and Histocompatibility, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, 41500, Larissa, Greece., Germanidis G; First Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, School of Medicine, 54636, Thessaloniki, Greece., Hytiroglou P; Department of Pathology, AHEPA Hospital, Aristotle University of Thessaloniki, School of Medicine, Kyriakidi Str. 1, 54636, Thessaloniki, Greece., Apostolou E; Centre for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, 11527, Athens, Greece., Vassiliadis T; Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403, Thessaloniki, Greece., Patsiaoura K; Department of Pathology, Hippokration Hospital, 54635, Thessaloniki, Greece., Sideras P; Centre for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, 11527, Athens, Greece., Germenis AE; Department of Immunology and Histocompatibility, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, 41500, Larissa, Greece., Speletas M; Department of Immunology and Histocompatibility, University of Thessaly, School of Health Sciences, Faculty of Medicine, Biopolis, 41500, Larissa, Greece. maspel@med.uth.gr.

Publikováno v: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2016 May; Vol. 65 (5), pp. 355-65. Date of Electronic Publication: 2016 Feb 09.

273 TGF-p and SMAD proteins participate in the fibrotic process of liver disease in cystic fibrosis

Autor: Sotiriadou, F, Fotoulaki, M., Argentou, N., Nousia-Arvanitakis, S., Chitiroglou, P., Tsitouridis, I., Speletas, M.

Publikováno v: In Journal of Cystic Fibrosis 2011 10 Supplement 1:S69-S69

Uncovering Novel Roles of miR-122 in the Pathophysiology of the Liver: Potential Interaction with NRF1 and E2F4 Signaling.

Autor: Paluschinski, Martha¹ (AUTHOR) martha.paluschinski@hhu.de, Schira-Heinen, Jessica^2,3 (AUTHOR) j.schira@hhu.de, Pellegrino, Rossella⁴ (AUTHOR) rossella.pellegrino@med.uni-heidelberg.de, Heij, Lara R.⁵ (AUTHOR) lheij@ukaachen.de, Bednarsch, Jan⁵ (AUTHOR) jbednarsch@ukaachen.de, Neumann, Ulf P.⁵ (AUTHOR) uneumann@ukaachen.de, Longerich, Thomas⁴ (AUTHOR) thomas.longerich@med.uni-heidelberg.de, Stuehler, Kai³ (AUTHOR), Luedde, Tom¹ (AUTHOR) tom.luedde@med.uni-duesseldorf.de, Castoldi, Mirco¹ (AUTHOR) mirco.castoldi@med.uni-duesseldorf.de

Publikováno v: Cancers. Aug2023, Vol. 15 Issue 16, p4129. 20p.